Neuropace Inc reports results for the quarter ended in September - Earnings Summary

NeuroPace

08/11/2022 22:53

* Neuropace Inc  NPCE.OQ  reported a quarterly adjusted loss
of 48
cents​​ per share for the quarter ended in September. The mean
expectation of three analysts for the quarter was for a loss
of 53 cents per share.
    * Revenue rose 7.9% to $11.16 million from a year ago;
analysts
expected $9.89 million. 
    * Neuropace Inc's reported EPS for the quarter was a loss
of 48
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuropace Inc shares had fallen by 37.9% this quarter and
lost 76.9% so far this year.
    * The company reported a quarterly loss of $11.79 million.
    * Wall Street's median 12-month price target for Neuropace
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 10:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.44          -0.52          Missed
 Mar. 31 2022      -0.44          -0.47          Missed
 Dec. 31 2021      -0.33          -0.44          Missed